IL103341A - IFN-c OR IL-2 OR A COMBINATION THEREOF FOR USE AGAINST INFECTION IN TRANSPLANT RECIPIENTS - Google Patents

IFN-c OR IL-2 OR A COMBINATION THEREOF FOR USE AGAINST INFECTION IN TRANSPLANT RECIPIENTS

Info

Publication number
IL103341A
IL103341A IL103341A IL10334192A IL103341A IL 103341 A IL103341 A IL 103341A IL 103341 A IL103341 A IL 103341A IL 10334192 A IL10334192 A IL 10334192A IL 103341 A IL103341 A IL 103341A
Authority
IL
Israel
Prior art keywords
ifn
combination
transplant recipients
against infection
use against
Prior art date
Application number
IL103341A
Other languages
English (en)
Other versions
IL103341A0 (en
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of IL103341A0 publication Critical patent/IL103341A0/xx
Publication of IL103341A publication Critical patent/IL103341A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL103341A 1991-10-07 1992-10-05 IFN-c OR IL-2 OR A COMBINATION THEREOF FOR USE AGAINST INFECTION IN TRANSPLANT RECIPIENTS IL103341A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/773,382 US5248499A (en) 1991-10-07 1991-10-07 Control of microbial infections in transplant patients

Publications (2)

Publication Number Publication Date
IL103341A0 IL103341A0 (en) 1993-03-15
IL103341A true IL103341A (en) 1997-11-20

Family

ID=25098084

Family Applications (1)

Application Number Title Priority Date Filing Date
IL103341A IL103341A (en) 1991-10-07 1992-10-05 IFN-c OR IL-2 OR A COMBINATION THEREOF FOR USE AGAINST INFECTION IN TRANSPLANT RECIPIENTS

Country Status (20)

Country Link
US (1) US5248499A (de)
EP (1) EP0607258B1 (de)
JP (1) JP3467037B2 (de)
KR (1) KR100262063B1 (de)
AT (1) ATE146967T1 (de)
AU (1) AU666138B2 (de)
CA (1) CA2119236C (de)
DE (1) DE69216419T2 (de)
DK (1) DK0607258T3 (de)
ES (1) ES2097929T3 (de)
FI (1) FI941552L (de)
GR (1) GR3022672T3 (de)
HU (1) HU226455B1 (de)
IL (1) IL103341A (de)
NO (1) NO313576B1 (de)
NZ (1) NZ244615A (de)
PH (1) PH30211A (de)
PT (1) PT100932B (de)
WO (1) WO1993006847A1 (de)
ZA (1) ZA927677B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9724838D0 (en) * 1997-11-26 1998-01-21 Franks Christopher R Compositions
JP2003510295A (ja) * 1999-09-28 2003-03-18 アマリロ バイオサイエンシズ,インコーポレイテッド 疾患の治療のための低投与量のifnガンマ
US20020150541A1 (en) * 2000-09-12 2002-10-17 Gene Trol Biotherapeutics, Inc. Compositions comprising mixtures of therapeutic proteins and methods of producing the same
US20030129162A1 (en) * 2000-09-12 2003-07-10 Lau Allan S. Compositions comprising mixtures of therapeutic proteins and methods of producing the same
EP1318834A2 (de) * 2000-09-12 2003-06-18 Genetrol Biotherapeutics, Inc. Zusammensetzung, die eine mischung von menschlichen zytokinen enthält, sowie verfahren für ihre herstellung
JP4394350B2 (ja) * 2001-01-09 2010-01-06 ベイラー リサーチ インスティテュート 対象における自己免疫疾患の治療法及びinvitro診断アッセイ
AUPR381601A0 (en) * 2001-03-19 2001-04-12 Monash University Method of treating respiratory conditions
EP1435910B9 (de) * 2001-10-19 2010-02-03 Isotechnika Inc. Neue cyclosporin-analoge mikroemulsionsvorkonzentrate
WO2005046746A2 (en) * 2003-11-10 2005-05-26 Angiotech International Ag Medical implants and fibrosis-inducing agents
US20070116678A1 (en) * 2005-11-23 2007-05-24 Hsing-Wen Sung Medical device with living cell sheet

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2237767A (en) * 1989-11-09 1991-05-15 Cosgrove Tools Ltd Moulding machine ejector devices

Also Published As

Publication number Publication date
FI941552A0 (fi) 1994-04-05
HUT67008A (en) 1995-01-30
GR3022672T3 (en) 1997-05-31
DE69216419T2 (de) 1997-06-26
HU226455B1 (en) 2008-12-29
PT100932A (pt) 1993-10-29
US5248499A (en) 1993-09-28
NZ244615A (en) 1997-06-24
AU2762292A (en) 1993-05-03
EP0607258B1 (de) 1997-01-02
KR100262063B1 (ko) 2000-07-15
NO941242L (no) 1994-06-03
DK0607258T3 (da) 1997-04-14
WO1993006847A1 (en) 1993-04-15
NO313576B1 (no) 2002-10-28
AU666138B2 (en) 1996-02-01
EP0607258A1 (de) 1994-07-27
FI941552A7 (fi) 1994-04-05
PH30211A (en) 1997-02-05
ZA927677B (en) 1994-04-07
ES2097929T3 (es) 1997-04-16
JPH07500106A (ja) 1995-01-05
CA2119236C (en) 2007-05-22
FI941552L (fi) 1994-04-05
IL103341A0 (en) 1993-03-15
ATE146967T1 (de) 1997-01-15
NO941242D0 (no) 1994-04-06
DE69216419D1 (de) 1997-02-13
JP3467037B2 (ja) 2003-11-17
CA2119236A1 (en) 1993-04-15
KR940702735A (ko) 1994-09-17
HU9400984D0 (en) 1994-07-28
PT100932B (pt) 1999-07-30

Similar Documents

Publication Publication Date Title
GR3032299T3 (en) Antiviral nucleoside combination.
DK0675708T3 (da) Farmaceutiske og dermokosmetiske sammensætninger indeholdende heste-colostrum.
GB2288732B (en) Pharmaceutical compositions
MD1224B2 (en) Application of nucleoside analogues with 1,3-oxathiolan for treatment of hepatitis B
DE69200837D1 (en) 3-difluoromethylpyrazolcarboxamidfungizide.
TR199802329T2 (xx) Enfeksiyon hastal�klar�n�n tedavisinde IL-12 ve IFNalfa kullan�m�.
CA2119006A1 (en) Composition and method of treating hepatitis c
ZA938702B (en) Mouthcare compositions
MXPA02010826A (es) Compuestos y metodos para el tratamiento y la prevencion de infeccion bacteriana.
GB2320431B (en) Compositions for the treatment of chronic wounds
GR3022672T3 (en) Use of ifn-gamma for the treatment of infections in transplant recipients.
ZA931318B (en) Method of treatment
PH27568A (en) Lactamimides in the treatment of drug-resistant protozoal infections
DK0484438T3 (da) Biologisk præparat og dets anvendelse
AU5871694A (en) Combination for treating hiv infections containing thymosine, interleukin and hiv replication or reverse transcriptase inhibitors
GR3024266T3 (en) Dental materials based on (meth)-acrylates
EP0863981A4 (de) Erkennung, vorbeugung und behandlung papillomatöser digitaler dermatitis
GB9802542D0 (en) New use
EP0490250A3 (en) Use of interferon and an antimalarial agent for the treatment of malarial infections
GB9111885D0 (en) Nerve growth factor for use in the prevention and treatment of viral infections
ZA901320B (en) Compositions for the treatment of microbial infections
IT1244360B (it) Preparato di zinco idrossido per la terapia nell'uomo dell'ulcera gastrica e duodenale

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired